PharmAust Limited (ASX – PAA) Secondary trading notice
170103_PHARMAUST LIMITED (ASX- PAA) – SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001
News & Announcements from PharmAust in 2016
PharmAust AGM presentation
161111_PharmAust AGM presentation
Non renounceable rights offer
161108_Non renounceable rights offer
Appendix 4C – Quarterly Report & Company Update for the period ended 30 September 2016
161031_Appendix 4C – Quarterly Report & Company Update for the period ended 30 September 2016
Second canine receives treatment in trial
161014_SECOND CANINE RECEIVES TREATMENT IN TRIAL
Phase II canine trial begins at the university of Cambridge
160919_PHASE II CANINE TRIAL BEGINS AT THE UNIVERSITY OF CAMBRIDGE
Epichem achieves ISO 90001-2015 certification
161016_EPICHEM ACHIEVES ISO 9001-2015 CERTIFICATION
MPL capsules shipped to centres in NSW & Qld for Phase II
161013_MPL capsules shipped to centres in NSW & Qld for Phase II
PharmAust Investor Presentation – June 2016
160829_PharmAust Investor Presentation – June 2016